Yahoo Poland Wyszukiwanie w Internecie

Search results

1. reference.medscape.com › drug › fosamax-binosto-alendronate-342810Fosamax, Binosto (alendronate) dosing, indications, interactions...

   reference.medscape.com › drug › fosamax-binosto-alendronate-342810

   • Zapisane w pamięci cache

   Medscape - Osteoporosis-specific dosing for Fosamax, Binosto (alendronate), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and...

2. www.ncbi.nlm.nih.gov › books › NBK526073Alendronate - StatPearls - NCBI Bookshelf - National Center for...

   www.ncbi.nlm.nih.gov › books › NBK526073

   5 lis 2019 · Alendronate belongs to the class of bisphosphonate medications and is used to treat osteoporosis and other bone-related conditions. By binding to hydroxyapatite crystals within bone, alendronate downregulates osteoclast-mediated bone reabsorption, thereby leading to a reduction in bone matrix breakdown.

3. pubmed.ncbi.nlm.nih.gov › 32728010Comparison table: some drugs for postmenopausal osteoporosis

   pubmed.ncbi.nlm.nih.gov › 32728010

   13 lip 2020 · MeSH terms Bone Density Conservation Agents / administration & dosage Bone Density Conservation Agents / adverse effects

4. www.drugs.com › pro › binostoBinosto: Package Insert / Prescribing Information - Drugs.com

   www.drugs.com › pro › binosto

   • Zapisane w pamięci cache

   2 sty 2024 · This randomized, double-blind, placebo-controlled, 4432-patient study (alendronate, n=2214; placebo, n=2218) further investigated the reduction in fracture incidence due to alendronate sodium.

5. pmc.ncbi.nlm.nih.gov › articles › PMC7716604Therapeutic Dimensions of Bisphosphonates: A Clinical Update

   pmc.ncbi.nlm.nih.gov › articles › PMC7716604

   Bisphosphonates (BPs) are a commonly used class of drugs for the treatment of bone disorders. An extensive review of BPs with their clinical efficacy and safety profile is unavailable. This study aimed to review the available literature on BPs, summarize their role in clinical therapy, and emphasize their safety profile.

6. www.accessdata.fda.gov › drugsatfda_docs › labelBINOSTO® (alendronate sodium) Effervescent Tablets - Food and...

   www.accessdata.fda.gov › drugsatfda_docs › label

   • Keep BINOSTO tablets in their original blister pack until you use them. • Protect BINOSTO from moisture. Keep BINOSTO and all medicines out of the reach of children.

7. www.accessdata.fda.gov › drugsatfda_docs › labelLabel: BINOSTO (alendronate sodium) - Food and Drug...

   www.accessdata.fda.gov › drugsatfda_docs › label

   BINOSTO (alendronate sodium) effervescent tablet 70 mg is bioequivalent to alendronate sodium tablet 70 mg. The fracture reduction efficacy and bone mineral density changes attributed to...